Alliqua BioMedical (Biologic Wound Care Assets) is Buildings and Property in United States that focus on ® therapy system business. They cover business area such as asset, all intellectual property, license, marketing, development, supply, agreement, Biovance® amniotic membrane allograft, Interfyl®, human connective tissue matrix, UltraMist® therapy system.
-
® Therapy System
-
2150 Cabot Boulevard West
Suite B
Langhorne, PA 19047
United States
Private
assetall intellectual propertylicensemarketingdevelopmentsupplyagreementBiovance® amniotic membrane allograftInterfyl®human connective tissue matrixUltraMist® therapy system
* We use standard office opening hours in near Alliqua BioMedical (Biologic Wound Care Assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Alliqua BioMedical (Biologic Wound Care Assets) is Buildings and Property business from United States that founded in - ( years old in ), Alliqua BioMedical (Biologic Wound Care Assets) business is focusing on ® Therapy System.
Alliqua BioMedical (Biologic Wound Care Assets) headquarter office and corporate office address is located in 2150 Cabot Boulevard West Suite B Langhorne, PA 19047 United States.
Alliqua BioMedical (Biologic Wound Care Assets) was founded in United States.
In , Alliqua BioMedical (Biologic Wound Care Assets) is currently focus on ® therapy system sector.
Above is snippet of Google Trends for "® therapy system" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Alliqua BioMedical (Biologic Wound Care Assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
